药品名称INFUVITE ADULT
申请号021163产品号001
活性成分ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
治疗等效代码参比药物是
批准日期2000/05/18申请机构SANDOZ CANADA INC
化学类型New formulation or new manufacturer审评分类Standard review drug
与本品相关的专利信息（来自橙皮书Orange Book）
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
无
历史专利信息
无
与本品相关的市场独占权保护信息
独占权代码失效日期
无
历史市场独占权保护信息
无
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
021163032APLabel2016/03/22下载
021163016APLetter2008/12/11下载
021163011APLabel2004/09/17下载
021163011APLetter2004/09/17下载
021163005APLetter2004/06/07下载
021163000APLetter2000/05/18下载
021163000APLabel2000/05/18下载
021163000APReview2004/03/28下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
021163032AP2016/03/17Labeling Revision
021163031AP2015/10/26Manufacturing Change or Addition
021163030AP2015/10/02Manufacturing Change or Addition
021163029AP2014/09/04Manufacturing Change or Addition
021163028AP2013/12/03Manufacturing Change or Addition
021163026AP2013/07/13Manufacturing Change or Addition
021163025AP2013/09/04Manufacturing Change or Addition
021163016AP2008/12/05Control Supplement
021163011AP2004/09/17Labeling Revision
021163005AP2003/02/12Labeling Revision
021163004AP2002/07/09Control Supplement
021163003AP2001/06/26Manufacturing Change or Addition
021163002AP2001/06/13Formulation Revision
021163000AP2000/05/18Approval